Aside from the potential curse of long COVID, people who've had the SARS-CoV-2 virus may be more likely to develop high ...

There is no cure. Between 1995 and 2021, around $42bn was poured into more than 1,000 clinical trials. Yet only a handful of ...

In a new study, participants who exercised 150 minutes per week—whether on one or two days, or more consistently—saw a host ...

The researchers theorise the protective effects of these drugs could be because they reduce inflammation, control infections ...

Nanyang Technological University, Singapore (NTU Singapore) spin-off company Gray Matter Solutions is partnering with Osler ...

A once-a-day pill that could be the “holy grail” in the treatment of Alzheimer’s disease is a step closer to becoming a ...

Research led by Lancaster University has revealed clear evidence that changes in the orchestration of brain oxygenation dynamics and neuronal function in Alzheimer's disease contribute to the ...